Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction

Objectives. To compare the use of an antireflux metal stent (ARMS) with that of a conventional covered self-expandable metal stent (c-CSEMS) for initial stenting of malignant distal biliary obstruction (MDBO). Materials and Methods. We retrospectively investigated 59 consecutive patients with unrese...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinichi Morita, Yasuaki Arai, Shunsuke Sugawara, Miyuki Sone, Yasunari Sakamoto, Takuji Okusaka, Shigetaka Yoshinaga, Yutaka Saito, Shuji Terai
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/3805173
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556069558157312
author Shinichi Morita
Yasuaki Arai
Shunsuke Sugawara
Miyuki Sone
Yasunari Sakamoto
Takuji Okusaka
Shigetaka Yoshinaga
Yutaka Saito
Shuji Terai
author_facet Shinichi Morita
Yasuaki Arai
Shunsuke Sugawara
Miyuki Sone
Yasunari Sakamoto
Takuji Okusaka
Shigetaka Yoshinaga
Yutaka Saito
Shuji Terai
author_sort Shinichi Morita
collection DOAJ
description Objectives. To compare the use of an antireflux metal stent (ARMS) with that of a conventional covered self-expandable metal stent (c-CSEMS) for initial stenting of malignant distal biliary obstruction (MDBO). Materials and Methods. We retrospectively investigated 59 consecutive patients with unresectable MDBO undergoing initial endoscopic biliary drainage. ARMS was used in 32 patients and c-CSEMS in 27. Technical success, functional success, complications, causes of recurrent biliary obstruction (RBO), time to RBO (TRBO), and reintervention were compared between the groups. Results. Stent placement was technically successful in all patients. There were no significant intergroup differences in functional success (ARMS [96.9%] versus c-CSEMS [96.2%]), complications (6.2 versus 7.4%), and RBO (48.4 versus 42.3%). Food impaction was significantly less frequent for ARMS than for c-CSEMS (P=0.037), but TRBO did not differ significantly between the groups (log-rank test, P=0.967). The median TRBO was 180.0 [interquartile range (IQR), 114.0–349.0] days for ARMS and 137.0 [IQR, 87.0–442.0] days for c-CSEMS. In both groups, reintervention for RBO was successfully completed in all patients thus treated. Conclusion. ARMS offers no advantage for initial stent placement, but food impaction is significantly prevented by the antireflux valve.
format Article
id doaj-art-69d05f79083b4688985e73bf6b0f7122
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-69d05f79083b4688985e73bf6b0f71222025-02-03T05:46:31ZengWileyGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/38051733805173Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary ObstructionShinichi Morita0Yasuaki Arai1Shunsuke Sugawara2Miyuki Sone3Yasunari Sakamoto4Takuji Okusaka5Shigetaka Yoshinaga6Yutaka Saito7Shuji Terai8Department of Gastroenterology and Hepatology, Uonuma Institute of Community Medicine, Niigata University Hospital, 4132 Urasa, Minamiuonuma, Niigata 949-7302, JapanDepartment of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Hepatology and Pancreatobiliary Internal Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Hepatology and Pancreatobiliary Internal Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanEndoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanEndoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, JapanDepartment of Gastroenterology and Hepatology, Niigata University Hospital, 754 Ichibancho, Asahimachidori, Chuo-ku, Niigata city, Niigata 951-8510, JapanObjectives. To compare the use of an antireflux metal stent (ARMS) with that of a conventional covered self-expandable metal stent (c-CSEMS) for initial stenting of malignant distal biliary obstruction (MDBO). Materials and Methods. We retrospectively investigated 59 consecutive patients with unresectable MDBO undergoing initial endoscopic biliary drainage. ARMS was used in 32 patients and c-CSEMS in 27. Technical success, functional success, complications, causes of recurrent biliary obstruction (RBO), time to RBO (TRBO), and reintervention were compared between the groups. Results. Stent placement was technically successful in all patients. There were no significant intergroup differences in functional success (ARMS [96.9%] versus c-CSEMS [96.2%]), complications (6.2 versus 7.4%), and RBO (48.4 versus 42.3%). Food impaction was significantly less frequent for ARMS than for c-CSEMS (P=0.037), but TRBO did not differ significantly between the groups (log-rank test, P=0.967). The median TRBO was 180.0 [interquartile range (IQR), 114.0–349.0] days for ARMS and 137.0 [IQR, 87.0–442.0] days for c-CSEMS. In both groups, reintervention for RBO was successfully completed in all patients thus treated. Conclusion. ARMS offers no advantage for initial stent placement, but food impaction is significantly prevented by the antireflux valve.http://dx.doi.org/10.1155/2018/3805173
spellingShingle Shinichi Morita
Yasuaki Arai
Shunsuke Sugawara
Miyuki Sone
Yasunari Sakamoto
Takuji Okusaka
Shigetaka Yoshinaga
Yutaka Saito
Shuji Terai
Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
Gastroenterology Research and Practice
title Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
title_full Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
title_fullStr Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
title_full_unstemmed Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
title_short Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction
title_sort antireflux metal stent for initial treatment of malignant distal biliary obstruction
url http://dx.doi.org/10.1155/2018/3805173
work_keys_str_mv AT shinichimorita antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT yasuakiarai antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT shunsukesugawara antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT miyukisone antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT yasunarisakamoto antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT takujiokusaka antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT shigetakayoshinaga antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT yutakasaito antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction
AT shujiterai antirefluxmetalstentforinitialtreatmentofmalignantdistalbiliaryobstruction